CG Oncology, Inc. Revenue 2023–2025
CG Oncology, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- CG Oncology, Inc. revenue for the quarter ending March 31, 2026 was 1.1 M, a 1982.69% increase year-over-year.
- CG Oncology, Inc. revenue for the twelve months ending March 31, 2026 was 2.8 M, a 304.77% increase year-over-year.
- CG Oncology, Inc. annual revenue for 2025 was 4.0 M, a 254.70% increase from 2024.
- CG Oncology, Inc. annual revenue for 2024 was 1.1 M, a 458.33% increase from 2023.
- CG Oncology, Inc. annual revenue for 2023 was 204000.
CG Oncology, Inc. (CGON) — Frequently Asked Questions
CG Oncology, Inc. (CGON) is a publicly traded US company. It has a market capitalization of $4.25B. In fiscal 2025 it reported revenue of $4M and net income of -$161M. Explore CGON's stock price, financial statements, earnings history, margins and key ratios below.
What is CG Oncology, Inc.'s market cap?
CG Oncology, Inc. (CGON) has a market capitalization of $4.25B.
What is the CGON stock price?
CGON trades at $54.92 (-3.09% on the day).
How much revenue does CG Oncology, Inc. make?
CG Oncology, Inc. reported revenue of $4M in fiscal 2025.
Is CGON profitable?
In fiscal 2025, CG Oncology, Inc. reported net income of -$161M.